№ lp_2_1_00829
File format: docx
Character count: 8765
File size: 604 KB
This document provides supplementary materials to a study on the relationship between the Body Roundness Index (BRI) and mortality risk, particularly in individuals with metabolic syndrome.
Year:
2023
Region / city:
Not specified
Topic:
Health, Mortality Risk, Body Roundness Index (BRI)
Document type:
Research Supplement
Institution:
Not specified
Author:
Not specified
Target audience:
Researchers, Public health professionals
Period of validity:
Not specified
Approval date:
Not specified
Date of modifications:
Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2014
Region / City:
N/A
Topic:
Strategic planning, budget approval, organizational updates
Document Type:
Meeting Minutes
Organization / Institution:
BRI (BEST Robotics, Inc.)
Author:
Board of Directors
Target Audience:
BRI board members, staff, and stakeholders
Period of Validity:
N/A
Approval Date:
January 24, 2014
Date of Changes:
N/A
Year:
2026
Company Name:
BRI DANAREKSA SEKURITAS
Abbreviated Name:
BRI DS
Type of Company:
NON-FACILITY LOCAL OWNED COMPANY
Company Status:
PRIVATE
Validity:
UNLIMITED
Notary Name:
JOSE DIMA SATRIA, SH., M.KN.
Notary Domicile:
SOUTH JAKARTA
Deed Number:
50
Deed Date:
15 April 2025
Company Address:
Gedung BRI II Lantai 23, Jalan Jendral Sudirman Kavling 44-46, BENDUNGAN HILIR, TANAH ABANG, CENTRAL JAKARTA, DKI JAKARTA
Postal Code:
10210
Board of Directors:
LAKSONO WIDITO WIDODO (Main Director), FIFI VIRGANTRIA, BONG (Director), SIRIH WAHYONO (Director)
Board of Commissioners:
ACHMAD ROYADI (Main Commissioner), R. MUHAMMAD IRWAN (Commissioner), DONSUWAN SIMATUPANG (Independent Commissioner)
Authorized Capital:
Rp 2,000,000,000,000
Issued Capital:
Rp 600,000,000,000
Paid Capital:
Rp 600,000,000,000
Shareholders:
PT DANAREKSA (PERSERO), PT BANK RAKYAT INDONESIA (Persero) Tbk
Business Activities:
Underwriter, Broker Dealer, Other Investment Management Companies
KBLI Year:
2020
Latest Amendment Type:
Notification of Changes to Company Data - Board of Directors and Commissioners
Date of Latest Amendment:
15 April 2025
ID of Latest SP Change:
AHU-AH.01.09-0189129
Position applied for:
Alcohol Support Worker (MAST, BRI)
Document type:
Employment application form
Purpose:
Collection of applicant personal information, employment history, qualifications, skills, references, and criminal conviction disclosures
Organization / Institution:
MAST, BRI
Sections included:
Personal information; Current employment; Previous employment (last 5 years); Qualifications; Skills, knowledge and experience; References; Criminal convictions; Signature
Personal data fields:
First name; Family name; Email address; Telephone number; Home address
Employment information fields:
Job title; Employer’s name and address; Start date; End date; Main duties
Qualification fields:
Subject; Qualification and grade; Education provider
Reference requirement:
Two referees including current or most recent employer
Background check authority:
Disclosure and Barring Service (DBS)
Legal declaration:
Disclosure of unspent criminal convictions or cautions
Authentication fields:
Signature; Date
Year:
2026
Region / city:
European Union
Topic:
Personalized Medicine for Cardiovascular, Metabolic, and Kidney Diseases
Document type:
Pre-proposal application form
Organization / Institution:
European Union Funding Agencies
Author:
Not specified
Target audience:
Research institutions, academic institutions, and industry partners
Duration:
Not specified
Approval date:
Not specified
Modification date:
Not specified
Contextual description:
A pre-proposal application form for the CARMEN2026 joint transnational call for proposals aimed at personalized medicine for cardiovascular, metabolic, and kidney diseases.
Year:
2023
Region / City:
N/A
Subject:
Genetic differentiation, metabolic analysis
Document Type:
Research Supplement
Institution:
N/A
Author:
N/A
Target Audience:
Researchers in genetics and agriculture
Period of Validity:
N/A
Approval Date:
N/A
Modification Date:
N/A
Year:
2023
Region / City:
Beijing, Shenzhen, Manchester, Baltimore
Topic:
Synthetic Biology, Metabolic Engineering, Protein-Protein Interaction
Document Type:
Research Article
Institution:
Tsinghua University, Shenzhen Institutes of Advanced Technology, University of Manchester, Johns Hopkins University
Author:
Tianyi Li, Xiuqi Chen, Yizhi Cai, Junbiao Dai
Target Audience:
Researchers, Biotechnologists, Academics
Effective Date:
2023
Modification Date:
Not specified
Year:
2025
Region / City:
Louisiana
Theme:
Nutrition, Obesity, Metabolic Health
Document Type:
Grant Application Guidelines
Organization:
Pennington Biomedical Research Center
Author:
Not specified
Target Audience:
Early-stage scientists, multidisciplinary teams, post-doctoral fellows
Period of Validity:
2025
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2023
Region / City:
Hyderabad, Telangana, India
Subject:
Metabolomics, Plasma Profiling, Pre-Diabetes, Non-Diabetic CP Patients
Document Type:
Supplementary Information
Organization / Institution:
Translational Research Centre, Asian Healthcare Foundation, AIG Hospitals, CSIR-Indian Institute of Chemical Technology
Authors:
Ketavarapu Vijayasarathy, Addipilli Ramunaidu, Nagarjunachary Ragi, Pallerla Pavankumar, Venu Simhadri, Suvidha Manne, Sannapaneni Krishnaiah, Mohsin Aslam, Rupjyoti Talukadar, Ch. Venkataramana Devi, G.V. Rao, Ramars Amanchy, D. Nageshwar Reddy, Prabhakar Sripadi, Mitnala Sasikala
Target Audience:
Researchers, Healthcare professionals in metabolomics and diabetes research
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2010-2024
Region / city:
Asia-Pacific
Subject:
Hepatology
Document Type:
Clinical Practice Guidelines
Organization / Institution:
Asian Pacific Association for the Study of the Liver (APASL)
Author:
APASL
Target Audience:
Healthcare professionals
Period of validity:
2010-2024
Date of approval:
2010
Date of revisions:
2024
Context:
Collection of clinical practice guidelines and consensus statements issued by the Asian Pacific Association for the Study of the Liver on various hepatological conditions, including hepatocellular carcinoma, hepatitis B and C, liver transplantation, and metabolic diseases.
Authors:
Luminari S; Donati B; Casali M; Valli R; Santi R; Puccini B; Kovalchuk S; Ruffini A; Fama A; Berti V; Fragliasso V; Zanelli M; Vergoni F; Versari A; Rigacci L; Merli F; Ciarrocchi A
Affiliations:
Hematology Unit, AUSL-IRCCS, Reggio Emilia; University of Modena and Reggio Emilia; Laboratory of Translational Research, AUSL-IRCCS, Reggio Emilia; Nuclear Medicine, AUSL-IRCCS, Reggio Emilia; Pathology Unit, AUSL IRCCS, Reggio Emilia; Pathology Unit, Careggi University Hospital, Firenze; Hematology, AOSP Careggi, Firenze; Gruppo Amici Dell’Ematologia Foundation (GrADE); Nuclear Medicine, University of Firenze; Hematology and Stem Cell Transplant AO San Camillo Forlanini, Roma
Corresponding authors:
Alessia Ciarrocchi; Stefano Luminari
Country:
Italy
Institutions:
AUSL-IRCCS Reggio Emilia; University of Modena and Reggio Emilia; Careggi University Hospital Firenze; University of Firenze; AO San Camillo Forlanini Roma
Medical field:
Hematology; Oncology; Molecular diagnostics
Disease:
Classical Hodgkin Lymphoma
Treatment regimen:
ABVD
Study population:
Previously untreated stage I–IV classical Hodgkin Lymphoma patients
Sample size:
238 patients (121 training set; 117 validation set)
Methodology:
Digital gene expression profiling (NanoString Technology); multivariate regression analysis; five-point Deauville scale assessment
Genes analyzed:
770 immune-related genes
Primary endpoint:
Prediction of interim FDG-PET positivity after two cycles of ABVD
Running title:
Gene predictive model for interim PET in Hodgkin Lymphoma
Keywords:
Hodgkin Lymphoma; metabolic response; interim PET; gene-based predictive model; tumor microenvironment
Word count:
4124
Year:
2023
Region / City:
United States
Topic:
Thrombopoiesis, Metabolic Syndrome, Inflammation, Platelet Counts
Document Type:
Research Article
Organization / Institution:
American University of Beirut, Lebanese University, University of Nicosia
Author:
Ali Hemade, Pascale Salameh
Target Audience:
Healthcare professionals, researchers in hematology and metabolic disorders
Period of Validity:
N/A
Approval Date:
N/A
Modification Date:
N/A
Year:
2025
Location:
Livingston, NJ, USA
Topic:
Metabolic Associated Steatotic Liver Disease (MASLD)
Document Type:
Continuing Medical Education (CME) Program Agenda
Organizing Institution:
Rutgers Health, Rutgers New Jersey Medical School
Departments:
Medicine, Surgery
Audience:
Gastroenterologists, hepatologists, surgeons, endocrinologists, primary care clinicians, nurses, pharmacists, physician assistants
Accreditation:
ACCME, ACPE, ANCC, AAPA
Credits:
4.75 AMA PRA Category 1 Credits™, 4.75 ANCC contact hours, 4.75 CPE contact hours, 4.75 AAPA Category 1 CME Credits
ABIM MOC Points:
Up to 4.75
Date:
Saturday, May 17, 2025
Location Address:
Eisenhower Conference Center, 290 West Mt. Pleasant Ave, Livingston, NJ 07039
Registration URL:
https://rutgers.cloud-cme.com/RUMASLD360
Program Chairs:
Paul J. Gaglio, MD; Faculty includes Kaveh Hajifathalian, MD, MPH; Daniel B. Jones, MD, MS; Bao-Ngoc Nasri, MD, PhD; Danbee H. Kim, MD; Dhvani Doshi, MD, MPH; Zaid Tafesh, MD, MSc
Year:
2026
Region / City:
Lausanne
Topic:
Medical research facilities access
Document type:
Visitor form
Organization:
CIBM EPFL
Author:
Not specified
Target audience:
Researchers and visitors to CIBM EPFL laboratories
Period of validity:
February 2026
Approval date:
Not specified
Modification date:
Not specified
Year:
2018
Region / City:
Colorado, USA
Subject:
Nutritional support / Metabolic formulas
Document Type:
Table / Reference chart
Organization:
Colorado WIC Program
Target Audience:
Infants, children with metabolic disorders, and women participating in WIC
Formula Type:
Powder and concentrate metabolic formulas
Age Groups:
0-3 months, 4-5 months, 6-11 months, 12 months+, women
Date of Issue:
06/01/2018
Source Type:
Government-issued dietary reference
Year:
2023
Region / City:
Not specified
Topic:
Biochemical processes, metabolism, energy production
Document Type:
Educational text
Organization / Institution:
Not specified
Author:
Not specified
Target Audience:
Students, researchers in biochemistry or related fields
Period of Validity:
Ongoing relevance
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2023
Region / City:
United States
Topic:
Metabolic and Bariatric Surgery
Document Type:
Application Form
Institution:
American Society for Metabolic and Bariatric Surgery (ASMBS)
Author:
American Society for Metabolic and Bariatric Surgery
Target Audience:
Integrated Health (IH) professionals in metabolic and bariatric surgery
Period of Validity:
N/A
Approval Date:
N/A
Date of Modifications:
N/A
Subject:
Metabolic syndrome
Topic:
Diagnostic criteria, risk factors, associated conditions, and management
Document type:
Educational test material
Content format:
Multiple choice questions
Medical focus:
Endocrinology and metabolic disorders
Diagnostic references:
IDF criteria
Key concepts:
Insulin resistance, central obesity, dyslipidemia, hypertension, hyperglycemia
Associated conditions:
Type 2 diabetes mellitus, cardiovascular disease, non-alcoholic fatty liver disease
Target audience:
Medical students or healthcare trainees
Year:
2020-2022
Region / City:
Wales
Topic:
Smoking-related health outcomes
Document Type:
Report
Organization / Institution:
Public Health Wales
Author:
Chris Emmerson, Hugo Cosh, Bethan Patterson, Rebecca Hughes
Target Audience:
Public health stakeholders, local health boards, government agencies
Period of validity:
2020-2022
Approval Date:
24 September 2024
Date of amendments:
Not specified
Year:
2023
Region / city:
Eastern Africa, South Sudan
Theme:
Visceral leishmaniasis treatment, clinical trial results, healthcare access
Document type:
Terms of Reference
Organization / institution:
DNDi, AfriKADIA Consortium, IMA World Health, WHO
Author:
Not specified
Target audience:
Healthcare professionals, researchers, policy makers
Period of validity:
Not specified
Approval date:
Not specified
Date of amendments:
Not specified
Note:
Contextual description